CD274 and metastatic neoplasm: Yang G et al. [29] developed a Hollow MnO2-based nano-platform H-MnO2-PEG/C&D combined with anti-PD-L1, which can activate tumor immunity in mice and significantly inhibit primary tumors and metastatic tumors.